Learn more

KANG STEM HOLDINGS CO LTD

Overview
  • Total Patents
    25
  • GoodIP Patent Rank
    211,005
About

KANG STEM HOLDINGS CO LTD has a total of 25 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are OPEXA THERAPEUTICS, EXCALIARD PHARMACEUTICALS INC and TRANSIMMUNE AG.

Patent filings in countries

World map showing KANG STEM HOLDINGS CO LTDs patent filings in countries
# Country Total Patents
#1 Republic of Korea 15
#2 WIPO (World Intellectual Property Organization) 8
#3 China 2

Patent filings per year

Chart showing KANG STEM HOLDINGS CO LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Biotechnology
#3 Measurement
#4 Machines

Top inventors

# Name Total Patents
#1 Kang Kyung Sun 25
#2 Park Sang Bum 7
#3 Seo Min Soo 7
#4 Kim Hyung Sik 4
#5 Yu Kyung Rok 4
#6 Lee Sung Hoon 2
#7 Seo Kwang Won 2
#8 Bhandari Dilli Ram 1
#9 Lee Seung Hee 1
#10 Kim Mi Hyun 1

Latest patents

Publication Filing date Title
KR101516763B1 Pharmaceutical composition comprising stem cells treated with DNA methyltransferase or culture thereof for prevention and treatment of immune diseases and inflammatory diseases
WO2013125899A1 Composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells as active ingredient
KR20130096661A A composition comprising stem cell for preventing or treating of immune or inflammatory disease
KR20130063483A Canine amniotic membrane-derived multipotent stem cells
KR20130116155A Direct preparation of functional insulin producing cell from human dermal fibroblasts
KR20120041706A Composition for anticancer containing umbilical cord blood- or adipose tissue-derived stem cell
KR20130056782A Equine amniotic membrane-derived mesenchymal stem cells
KR20130028294A Isolation and characterization of canine wharton's jelly-derived mesenchymal stem cells
WO2012033352A2 Equine amniotic fluid derived multipotent stem cells and a production method therefor
CN103118691A Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with NOD2 agonist or cultured product thereof
WO2011122889A2 Method for inhibiting the senescence of adult stem cells by inhibiting mirna expression
KR20120095257A A METHOD FOR PRODUCING PANCREAS β LIKE CELLS FROM ADULT STEM CELLS
WO2011087299A2 Pharmaceutical composition for the treatment of cancer, containing an extracellular matrix of mesenchymal stem cells derived from umbilical cord blood as an active ingredient